BioCentury | Feb 27, 2021
Translation in Brief

A $53M UC Berkeley-UCSF-Genentech-Roche collaboration on brain diseases; plus Selecta, JDRF-Harvard Stem Cell Institute, Tissue Dynamics and more

...Jardiance empagliflozin, an SGLT2 inhibitor from Boehringer Ingelheim GmbH.A new SARS-CoV-2 system to ease research bottlenecksScientists from University of Texas Medical Branch...
...CD274) – Programmed cell death 1 ligand 1 SGLT2 – Sodium-glucose cotransporter 2 (SGLT2) Danielle Golovin LYT-300 Arbutus Biopharma Corp. University of Texas Medical Branch Washington...
BioCentury | Jan 21, 2021
Product Development

How spike mutations in SARS-CoV-2 variants affect vaccines, therapies: Data Byte

...report comes two weeks after Pfizer and  University of Texas Medical Branch...
BioCentury | Jan 9, 2021
Product Development

COVID Roundup: No vaccine resistance from a mutation in U.K., South Africa rapid transmission variants; plus Moderna vaccine gains U.K. approval

...than 35 µL. Sandi Wong mRNA-1273 Comirnaty (PF-07302048, BNT162, BNT162b2) Moderna Inc. Pfizer Inc. University of Texas Medical Branch BioNTech...
BioCentury | Oct 17, 2020
Translation in Brief

SARS-CoV-2 infects brain choroid plexus, compromises CSF-blood barrier; plus Passage’s GM1 gangliosidosis gene therapy, a new COVID-19 reporter and more

...biomarker data in 1H21.Bioluminescent  SARS-CoV-2 reporterScientists from University of Texas Medical Branch...
...Research Council Laboratory of Molecular Biology (MRC LMB) University of Texas Medical Branch Gilead...
BioCentury | Apr 21, 2020
Product Development

Trio of tactics to target COVID-19 hyperinflammation

...HCV therapy, to treat COVID-19. The company said that a preprint in bioRxiv from the University of Texas Medical Branch...
BioCentury | Apr 17, 2020
Translation in Brief

SARS-CoV-2 fluorescent tool for drug development; plus Alzheimer's biomarkers, Nature, National Academies and Pylum

...DNA-based tool for developing COVID-19 countermeasures University of Texas Medical Branch researchers have created a fluorescent SARS-CoV-2 DNA clone as...
...Medical Branch unveiled the structural findings for the pore-forming proteins in Nature . Danielle Kopke, Staff Writer University of Texas Medical Branch University...
BioCentury | Feb 26, 2020
Product Development

COVID-19: A growing list of new vaccines and therapies in development

...& Johnson Inovio Pharmaceuticals Inc. Codagenix Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac N.V. Moderna Inc. GeoVax Labs Inc. Baylor College of Medicine University of Texas Medical Branch New...
BioCentury | Jan 31, 2020
Clinical News

A dozen vaccine programs under way as WHO declares coronavirus public health emergency

...& Johnson Inovio Pharmaceuticals Inc. Codagenix Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac N.V. Moderna Inc. GeoVax Labs Inc. Baylor College of Medicine University of Texas Medical Branch New...
BioCentury | Jan 25, 2020
Product Development

The race is on to develop therapies and vaccines for the coronavirus outbreak

...good match for 2012-nCov. If the SARS vaccine isn’t promising, the consortium, which includes the University of Texas Medical Branch...
BioCentury | Jan 23, 2020
Clinical News

Biopharma companies, academics, governments racing to develop medical countermeasures against novel coronavirus

...College of Medicine is developing a virus-like particle 2019-nCoV vaccine. It is collaborating with the University of Texas Medical Branch...
Items per page:
1 - 10 of 78
BioCentury | Feb 27, 2021
Translation in Brief

A $53M UC Berkeley-UCSF-Genentech-Roche collaboration on brain diseases; plus Selecta, JDRF-Harvard Stem Cell Institute, Tissue Dynamics and more

...Jardiance empagliflozin, an SGLT2 inhibitor from Boehringer Ingelheim GmbH.A new SARS-CoV-2 system to ease research bottlenecksScientists from University of Texas Medical Branch...
...CD274) – Programmed cell death 1 ligand 1 SGLT2 – Sodium-glucose cotransporter 2 (SGLT2) Danielle Golovin LYT-300 Arbutus Biopharma Corp. University of Texas Medical Branch Washington...
BioCentury | Jan 21, 2021
Product Development

How spike mutations in SARS-CoV-2 variants affect vaccines, therapies: Data Byte

...report comes two weeks after Pfizer and  University of Texas Medical Branch...
BioCentury | Jan 9, 2021
Product Development

COVID Roundup: No vaccine resistance from a mutation in U.K., South Africa rapid transmission variants; plus Moderna vaccine gains U.K. approval

...than 35 µL. Sandi Wong mRNA-1273 Comirnaty (PF-07302048, BNT162, BNT162b2) Moderna Inc. Pfizer Inc. University of Texas Medical Branch BioNTech...
BioCentury | Oct 17, 2020
Translation in Brief

SARS-CoV-2 infects brain choroid plexus, compromises CSF-blood barrier; plus Passage’s GM1 gangliosidosis gene therapy, a new COVID-19 reporter and more

...biomarker data in 1H21.Bioluminescent  SARS-CoV-2 reporterScientists from University of Texas Medical Branch...
...Research Council Laboratory of Molecular Biology (MRC LMB) University of Texas Medical Branch Gilead...
BioCentury | Apr 21, 2020
Product Development

Trio of tactics to target COVID-19 hyperinflammation

...HCV therapy, to treat COVID-19. The company said that a preprint in bioRxiv from the University of Texas Medical Branch...
BioCentury | Apr 17, 2020
Translation in Brief

SARS-CoV-2 fluorescent tool for drug development; plus Alzheimer's biomarkers, Nature, National Academies and Pylum

...DNA-based tool for developing COVID-19 countermeasures University of Texas Medical Branch researchers have created a fluorescent SARS-CoV-2 DNA clone as...
...Medical Branch unveiled the structural findings for the pore-forming proteins in Nature . Danielle Kopke, Staff Writer University of Texas Medical Branch University...
BioCentury | Feb 26, 2020
Product Development

COVID-19: A growing list of new vaccines and therapies in development

...& Johnson Inovio Pharmaceuticals Inc. Codagenix Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac N.V. Moderna Inc. GeoVax Labs Inc. Baylor College of Medicine University of Texas Medical Branch New...
BioCentury | Jan 31, 2020
Clinical News

A dozen vaccine programs under way as WHO declares coronavirus public health emergency

...& Johnson Inovio Pharmaceuticals Inc. Codagenix Inc. Novavax Inc. Sichuan Clover Biopharmaceuticals Inc. CureVac N.V. Moderna Inc. GeoVax Labs Inc. Baylor College of Medicine University of Texas Medical Branch New...
BioCentury | Jan 25, 2020
Product Development

The race is on to develop therapies and vaccines for the coronavirus outbreak

...good match for 2012-nCov. If the SARS vaccine isn’t promising, the consortium, which includes the University of Texas Medical Branch...
BioCentury | Jan 23, 2020
Clinical News

Biopharma companies, academics, governments racing to develop medical countermeasures against novel coronavirus

...College of Medicine is developing a virus-like particle 2019-nCoV vaccine. It is collaborating with the University of Texas Medical Branch...
Items per page:
1 - 10 of 78